Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (1)
Country
  • Bulgaria (1)
  • Canada (1)
  • Czech Republic (1)
  • France (1)
  • Germany (1)
  • Hungary (1)
  • Italy (1)
  • Spain (1)
  • Turkey (1)
  • Ukraine (1)
  • United Kingdom (1)
  • United States (1)
Source
  • nct (1)
Phase
  • complete (1)

Country: Canada,Turkey,Hungary,France,Germany,Bulgaria - Promoter: nct
nct Update Il y a 5 ans

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer The purpose of this study is to compare progression free survival for SU011248 [sutent (sunitinib malate)] versus standard of care therapy in patients with previously treated, advanced, triple receptor negative (ER, PR, HER2) locally recurrent or metastatic breast cancer.

  • Country Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Spain, Turkey, Ukraine, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.